Heavy metals become toxic when they are not metabolized by the body and accumulate in the soft tissue. Chelation therapy is mainly for the management of heavy metal–induced toxicity; however, it usually causes adverse effects or completely blocks the vital function of the particular metal chelated. Much attention has been paid to the development of chelating agents from natural sources to counteract lead- and iron-induced hepatic and renal damage. Sesame oil (a natural edible oil) and sesamol (an active antioxidant) are potently beneficial for treating lead- and iron-induced hepatic and renal toxicity and have no adverse effects. Sesame oil and sesamol significantly inhibit iron-induced lipid peroxidation by inhibiting the xanthine oxidase, nitric oxide, superoxide anion, and hydroxyl radical generation. In addition, sesame oil is a potent inhibitor of proinflammatory mediators, and it attenuates lead-induced hepatic damage by inhibiting nitric oxide, tumor necrosis factor–α, and interleukin-1β levels. Because metal chelating therapy is associated with adverse effects, treating heavy metal toxicity in addition with sesame oil and sesamol may be better alternatives. This review deals with the possible use and beneficial effects of sesame oil and sesamol during heavy metal toxicity treatment.
BeyersmannDHartwigA. Carcinogenic metal compounds: recent insight into molecular and cellular mechanisms. Arch Toxicol. 2007;82:493-512.
2.
NieboerEFletcherGGThomassenY. Relevance of reactivity determinants to exposure assessment and biological monitoring of the elements. J Environ Monit. 1999;1:1-14.
3.
HartwigA. Zinc finger proteins as potential targets for toxic metal ions: differential on structure and function. Antioxid Redox Signal. 2001;3:625-634.
4.
NeedlemanHL. Lead poisoning. Ann Rev Med. 2004;55:209-222.
5.
CarlisleJCDowlingKCSiegelDMAlexeeffGV. A blood lead benchmark for assessing risks from childhood lead exposure. J Environ Sci Health A Tox Hazard Subst Environ Eng. 2009;44:1200-1208.
6.
SattarAWahidMDurraniSK. Concentration of selected heavy metals in spices, dry fruits and plant nuts. Plant Foods Hum Nutr. 1989;39:279-286.
7.
LanphearBPDietrichKAuingerPCoxC. Cognitive deficits associated with blood lead concentrations <10 µg/dL in US children and adolescents. Public Health Rep. 2000;115:521-529.
8.
LanphearBPHornungRKhouryJ. Low-level environmental lead exposure and children’s intellectual function: an international pooled analysis. Environ Health Perspect. 2005;113:894-899.
9.
GoyerRAClarksonTW. Toxic effects of metals. In: KlaassenCD, ed. Casarett and Doull’s Toxicology: The Basic Science of Poisons. 6th ed.New York, NY: McGraw-Hill; 2001:811-868.
10.
Navas-AcienAGuallarESilbergeldEKRothenbergSJ. Lead exposure and cardiovascular disease-a systematic review. Environ Health Perspect. 2007;115:472-482.
11.
EkongEJaarBWeaverV. Lead-related nephrotoxicity: a review of the epidemiologic evidence. Kidney Int. 2006;70:2074-2084.
12.
RegleroMMTaggartMAMonsalve-GonzalezLMateoR. Heavy metal exposure in large game from a lead mining area: effects on oxidative stress and fatty acid composition in liver. Environ Pollut. 2009;157:1388-1395.
13.
DoumouchtsisKKDoumouchtsisSKDoumouchtsisEKPerreaDN. The effect of lead intoxication on endocrine functions. J Endocrinol Invest. 2009;32:175-183.
14.
AndersonGJ. Mechanism of iron loading and toxicity. Am J Hematol. 2007;82:1128-1131.
15.
TenenbeinM. Hepatotoxicity in acute iron poisoning. J Toxicol Clin Toxicol. 2001;39:721-726.
16.
BergDGerlachMYoudimMB. Brain iron pathways and their relevance to Parkinson’s disease. J Neurochem. 2001;79:225-236.
17.
SiahCWTrinderDOlynykJK. Iron overload. Clin Chim Acta. 2005;358:24-36.
18.
UllenHAugustssonKGustavssonCSteineckG. Supplementary iron intake and risk of cancer: reversed causality?Cancer Lett. 1997;114:215-216.
19.
Antonio-GarciaMTMasso-GonzalezEL. Toxic effects of perinatal lead exposure on the brain of rats: involvement of oxidative stress and the beneficial role of antioxidants. Food Chem Toxicol. 2008;46:2089-2095.
20.
NemsadzeKSanikidzeTRatianiLGabuniaLSharashenidzeT. Mechanisms of lead-induced poisoning. Georgian Med News. 2009;172-173:92-96.
21.
KasperczykSKasperczykJOstałowskaA. The role of the antioxidant enzymes in erythrocytes in the development of arterial hypertension among humans exposed to lead. Biol Trace Elem Res. 2009;130:95-106.
22.
SandhirRGillKD. Effect of lead on lipid peroxidation in liver of rats. Biol Trace Elem Res. 1995;48:91-97.
23.
Aykin-BurnsNLaegelerAEllogGErcalN. Oxidative effects of lead in young and adult Fisher 344 rats. Arch Environ Contam Toxicol. 2003;44:417-420.
24.
GelmanBBMichaelsonIABusJS. The effect of lead on oxidative hemolysis and erythrocyte defense mechanisms in the rat. Toxicol Appl Pharmacol. 1978;45:119-129.
25.
SchrauzerGN. Effects of selenium antagonists on cancer susceptibility: new aspects of chronic heavy metal toxicity. J UOEH. 1987;9:208-215.
26.
OthmanAIEl MissiryMA. Role of selenium against lead toxicity in male rats. J Biochem Mol Toxicol. 1998;12:345-349.
27.
MushakP. Lead and Public Health: Science, Risk, and Regulation. Amsterdam, the Netherlands: Elsevier; 2011:609-610.
28.
SiegDJBillingsRE. Lead/cytokine-mediated oxidative DNA damage in cultured mouse hepatocytes. Toxicol Appl Pharmacol. 1997;142:106-115.
29.
MilosevicNMaierP. Lead stimulates intercellular signaling between hepatocytes and Kupffer cells. Eur J Pharmacol. 2000;401:317-328.
30.
HalliwellBGutteridgeJM. Protection against oxidants in biological systems: the superoxide theory of oxygen toxicity. In: HalliwellBGutteridgeJM, eds. Free Radical in Biology and Medicine. Oxford, UK: Clarendon; 1989:86-123.
31.
PietrangeloA. Iron-induced oxidant stress in alcoholic liver fibrogenesis. Alcohol. 2003;30:121-129.
32.
SiesH. Oxidative stress: from basic research to clinical application. Am J Med. 1991;91:S31-S38.
33.
AndersenO. Oral cadmium exposure in mice: toxicokinetics and efficiency of chelating agents. CRC Crit Rev Toxicol. 1989;20:83-112.
34.
AndersenO. Choice of chelating antidotes for acute cadmium intoxication. Toxicol Environ Chem. 1989;23:105-120.
35.
AndersenOAasethJ. Molecular mechanisms of in vivo metal chelation: implications for clinical treatment of metal intoxications. Environ Health Perspect. 2002;110:887-890.
36.
SaxenaGFloraSJ. Changes in brain biogenic amines and heme biosynthesis and their response to combined administration of succimer and Centella asiatica in lead poisoned rats. J Pharm Pharmacol. 2006;58:547-559.
37.
MishraDGuptaRPantSCKushwahPSatishHTFloraSJ. Therapeutic potential of combined administration of MiADMSA and Moringa oleifera seed powder on arsenic induced oxidative stress and metal distribution in mouse. Toxicol Mechanism Meth. 2008;19:169-182.
38.
FloraSJMehtaAGuptaR. Prevention of arsenic-induced hepatic apoptosis by concomitant administration of garlic extracts in mice. Chem Biol Inter. 2009;177:227-233.
39.
SimonJEChadwickAFCrakerLE. Herbs: An Indexed Bibliography, 1971-1980: The Scientific Literature on Selected Herbs, and Aromatic and Medicinal Plants of the Temperate Zone. Hamden, CT: Archon; 1984. http://www.hort.purdue.edu/newcrop/med-aro/factsheets/SESAME.html. Accessed April 2, 2013.
40.
FukudaYOsawaTNamikiMOzakiT. Studies on antioxidative substances in sesame seed. Agric Biol Chem. 1985;49:301-306.
41.
NamikiM. The chemistry and physiological function of sesame. Food Rev Int. 1995;11:281-329.
42.
KangMHKatsuzakiHOsawaT. Inhibition of 2,2′-azinobis(2,4-dimethylvaleronitrile)–induced lipid peroxidation by sesaminols. Lipids. 1998;33:1031-1036.
43.
KangMHNaitoMTsujioharaNOsawaT. Sesamolin inhibits lipid peroxidation in rat liver and kidney. J Nutr. 1998;128:1018-1022.
BabaNHAntoniadesKHabbalZ. Effects of dietary canola, olive, and linolenic acid enriched olive oils on plasma lipids, lipid peroxidation and lipoprotein lipase activity in rats. Nutr Res. 1999;19:601-612.
46.
SankarDSambandamGRamakrishna RaoMPugalendiKV. Modulation of blood pressure, lipid profiles and redox status in hypertensive patients taking different edible oils. Clin Chim Acta. 2005;355:97-104.
47.
KapadiaGJAzuineMATokudaH. Chemopreventive effect of resveratrol, sesamol, sesame oil and sunflower oil in the Epstein-Barr virus early antigen activation assay and the mouse skin two-stage carcinogenesis. Pharmacol Res. 2002;45:499-504.
48.
FukudaY. Food chemical studies on the antioxidants in sesame seed. Nippon Shokuhin Kogyo Gakkaishi. 1990;37:484-492.
49.
ChandrasekaranVRChienSPHsuDZLiuMY. Anti-hepatotoxic effects of 3,4-methylenedioxyphenol and N-acetylcysteine in acutely acetaminophen-overdosed mice. Hum Exp Toxicol. 2011;30:1609-1615.
50.
PeriasamySHsuDZChenSYYangSSChandrasekaranVRLiuMY. Sesamol therapeutically attenuates monocrotaline-induced sinusoidal obstruction syndrome via inhibition of matrix metalloproteinase-9 in rats. Cell Biochem Biophys. 2011;61:327-336.
51.
KimJYChoiDSJungMY. Antiphoto-oxidative activity of sesamol in methyleneblue- and chlorophyll-sensitized photo-oxidation of oil. J Agric Food Chem. 2003;51:3460-3465.
52.
JoshiRKumarMSSatyamoorthyKUnnikrisnanMKMukherjeeT. Free radical reactions and antioxidant activities of sesamol: pulse radiolytic and biochemical studies. J Agric Food Chem. 2005;53:2696-2703.
53.
MazzioEAHarrisNSolimanKF. Food constituents attenuate monoamine oxidase activity and peroxide levels in C6 astrocyte cells. Planta Med. 1998;64:603-606.
54.
El-AdawyTA. Effect of sesame seed proteins supplementation on the nutritional, physical, chemical and sensory properties of wheat flour bread. Plant Foods Hum Nutr. 1995;48:311-326.
55.
EgbekunMKEhiezeMU. Proximate composition and functional properties of fullfat and defatted beniseed (Sesamum indicum L.) flour. Plant Foods Hum Nutr. 1997;51:35-41.
56.
NamikiM. Nutraceutical functions of sesame: a review. Crit Rev Food Sci Nutr. 2007;47:651-673.
57.
AsokanSKumarRSEmmadiPRaghuramanRSivakumarN. Effect of oil pulling on halitosis and microorganisms causing halitosis: a randomized controlled pilot trial. J Indian Soc Pedod Prev Dent. 2011;29:90-94.
58.
HsuDZChienSPChenHTLiuMY. The effect of sesamol on systemic oxidative stress and hepatic dysfunction in acutely iron-intoxicated mice. Shock. 2007;28:596-601.
59.
HsuDZChenKTChienSP. Sesame oil attenuates acute iron induced lipid peroxidation-associated hepatic damage in mice. Shock. 2006;26:625-630.
60.
HsuDZChuPYLiuMY. Effect of sesame oil on acidified ethanol-induced gastric mucosal injury in rats. JPEN J Parenter Enteral Nutr. 2009;33:423-427.
61.
ChandrasekaranVRWanCHLiuLLHsuDZLiuMY. Effect of sesame oil against acetaminophen-induced acute oxidative hepatic damage in rats. Shock. 2008;30:217-221.
62.
JanKCHoCTHwangLS. Bioavailability and tissue distribution of sesamol in rat. J Agric Food Chem. 2008;56:7032-7037.
63.
LiuMYChengYJChenCKYangBC. Co-exposure of lead and lipopolysaccharide-induced liver injury in rats: involvement of nitric oxide-initiated oxidative stress and TNF-α. Shock. 2005;23:360-364.
64.
ChengYJLiuMY. Modulation of tumor necrosis factor-α and oxidative stress through protein kinase C and p42/44 mitogen-activated protein kinase in lead increases lipopolysaccharide-induced liver damage in rats. Shock. 2005;24:188-193.
65.
ChengYJYangBCLiuMY. Lead increases lipopolysaccharide-induced liver injury through tumor necrosis factor–α overexpression by monocytes/macrophages: role of protein kinase C and p42/44 mitogen-activated protein kinase. Environ Health Perspect. 2006;114:507-513.
66.
DentenerMAGreveJWMaessenJGBuurmanWA. Role of tumour necrosis factor in the enhanced sensitivity of mice to endotoxin after exposure to lead. Immunopharmacol Immunotoxicol. 1989;11:321-334.
67.
HonchelRMarsanoLCohenDShedlofskySMcClainCJ. Lead enhances IL-1 and TNF mRNA expression and the LPS-, IL-1-, and TNF-induced inflammatory infiltrate. Am J Pathol. 1991;138:1485-1496.
68.
LeistMGantnerFJilgSWendelA. Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release. J Immunol. 1995;154:1307-1316.
69.
HsuDZSuSBChienSP. Effect of sesame oil on oxidative-stress–associated renal injury in endotoxemic rats: involvement of nitric oxide and proinflammatory cytokines. Shock. 2005;24:276-280.
StalP. Iron as a hepatotoxin. Dig Dis. 1995;13:205-222.
72.
RobertsonATenenbeinM. Hepatotoxicity in acute iron poisoning. Hum Exp Toxicol. 2005;24:559-562.
73.
HsuDZWanCHHsuHFLinYMLiuMY. The prophylactic protective effect of sesamol against ferric-nitrilotriacetate–induced acute renal injury in mice. Food Chem Toxicol. 2008;46:2736-2741.
EbinaYOkadaSHamazakiSOginoFLiJLMidorikawaO. Nephrotoxicity and renal cell carcinoma after use of iron- and aluminum-nitrilotriacetate complexes in rats. J Natl Cancer Inst. 1986;76:107-113.
76.
LiYHChienSPChuPYLiuMY. Prophylactic and therapeutic effects of a subcutaneous injection of sesame oil against iron-induced acute renal injury in mice. JPEN J Parenter Enteral Nutr. 2012;33:344-348.
77.
JadayilSATukanSKTakruriHR. Bioavailability of iron from four different local food plants in Jordan. Plant Foods Hum Nutr. 1999;54:285-294.
78.
ChandrasekaranVRHsuDZLiuMY. The protective effect of sesamol against mitochondrial oxidative stress and hepatic injury in acetaminophen-overdosed rats. Shock. 2009;32:89-93.
79.
HsuDZChenKTLinTHLiYHLiuMY. Sesame oil attenuates cisplatin-induced hepatic and renal injuries by inhibiting nitric oxide–associated lipid peroxidation in mice. Shock. 2007;27:199-204.
80.
Treatment guidelines for lead exposure in children. American Academy of Pediatrics Committee on Drugs. Pediatrics. 1995;96:155-160.
81.
PorruSAlessioL. The use of chelating agents in occupational lead poisoning. Occup Med. 1996;46:41-48.
82.
MortensenMEWalsonPD. Chelation therapy for childhood lead poisoning. Clin Pediatr (Phila.). 1993;32:284-291.
83.
PiomelliSRosenJFChisolmJJJrGraefJW. Management of childhood lead poisoning. J Pediatr. 1984;105:523-532.
84.
PiomelliS. Lead poisoning. In: NathanDGOskiFA eds. Hematology of Infancy and Childhood. Philadelphia, PA: Saunders; 1993:472-494.
85.
MoelDIKumarK. Reversible nephrotoxic reactions to a combined 2,3-dimercapto-1-propanol and calcium disodium ethylenediaminetetraacetic acid regimen in asymptomatic children with elevated blood lead levels. Pediatrics. 1982;70:259-262.
86.
KlaassenCD. Heavy metals and heavy metal antagonists. In: GilmanAGRallTWNiesASTaylorP, eds. Goodman & Gilman’s The Pharmacological Basis of Therapeutics. New York, NY: Pergamon; 1990.
87.
Centers for Disease Control. Preventing Lead Poisoning in Young Children. Atlanta, GA: US Department of Health and Human Services; 1991.
88.
AposhianHVMaiorinoRMGonzales-RamirezD. Mobilization of heavy metals by newer, therapeutically useful chelating agents. Toxicology. 1995;97:23-38.
89.
Cory-SlechtaDAWeissBCoxC. Mobilization and redistribution of lead over the course of calcium disodium ethylenediamine tetraacetate chelation therapy. J Pharmacol Exp Ther. 1987;243:804-813.
90.
ChisolmJJ. Evaluation of the potential role of chelation therapy in treatment of low to moderate lead exposure. Environ Health Perspect. 1990;89:67-74.
91.
SachsHKBlanksmaLAMurrayEFO’ConnellMJ. Ambulatory treatment of lead poisoning: report of 1155 cases. Pediatrics. 1970;46:389-396.
92.
VitaleLFRosalinas-BailonAFollandDBrennanJFMcCormickB. Oral penicillamine therapy for chronic lead poisoning in children. J Pediatr. 1973;83:1041-1045.
93.
ShannonMGraefJLovejoyFHJr. Efficacy and toxicity of D-penicillamine in low-level lead poisoning. J Pediatr. 1988;112:799-804.
94.
OsmanMAPatelRBSchunaASundstromWRWellingPG. Reduction in oral penicillamine absorption by food, antacid, and ferrous sulfate. Clin Pharmacol Ther. 1983;33:465-470.
95.
IfanAWellingPG. Pharmacokinetics of oral 500 mg penicillamine: effects of antacids on absorption. Biopharm Drug Dispos. 1986;7:401-405.
96.
LiebeltELShannonMW. Oral chelators for childhood lead poisoning. Pediatr Ann. 1994;23:616-626.
97.
JorgensenFM. Succimer: the first approved oral lead chelator. Am Fam Physician. 1993;48:1496-1502.
98.
MannKVTraversJD. Succimer, an oral chelator. Clin Pharm. 1991;10:914-922.
99.
LeyTJGriffithPNienhuisAW. Transfusion haemosiderosis and chelation therapy. Clin Haematol. 1982;11:437-445.
100.
FlynnDMHoffbrandAVPolitisD. Subcutaneous desferrioxamine: the effect of three years’ treatment on liver, iron, serum ferritin, and comments on echocardiography. Birth Defects. 1982;18:347-353.
101.
RahkoPSSalerniRUretskyBF. Successful reversal by chelation therapy of congestive cardiomyopathy due to iron overload. J Am Coll Cardiol. 1986;8:436-440.
OlivieriNFBrittenhamGMMcLarenCE. Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major. N Engl J Med. 1998;339:417-423.
104.
HsuDZLiuCTLiYHChuPYLiuMY. Protective effect of daily sesame oil supplement on gentamicin-induced renal injury in rats. Shock. 2010;33:88-92.
105.
PeriasamySLiuCTHsuDZLiuMY. Sesame oil accelerates kidney healing following gentamicin-induced kidney injury in rats. Am J Nephrol. 2010;32:383-392.
106.
HsuDZLiYHChuPYPeriasamySLiuMY. Sesame oil prevents acute kidney injury induced by the synergistic action of aminoglycoside and iodinated contrast in rats. Antimicrob Agents Chemother. 2011;55:2532-2536.
107.
ChandrasekaranVRChienSPHsuDZChangYCLiuMY. Effects of sesame oil against after the onset of acetaminophen-induced acute hepatic injury in rats. JPEN J Parenter Enteral Nutr. 2010;34:567-573.
108.
HsuDZLiuMY. Sesame oil protects against lipopolysaccharide-stimulated oxidative stress in rats. Crit Care Med. 2004;32:227-231.
109.
HsuDZSuSBChienSP. Effect of sesame oil on oxidative-stress–associated renal injury in endotoxemic rats: involvement of nitric oxide and proinflammatory cytokines. Shock. 2005;24:276-280.
110.
HsuDZChuPYLiYHLiuMY. Sesamol attenuates diclofenac-induced acute gastric mucosal injury via its cyclooxygenase-independent antioxidative effect in rats. Shock2008;30:456-462.
111.
HsuDZChuPYChandrasekaranVRLiuMY. Sesamol protects against aspirin-induced gastric mucosal damage in rats. J Funct Foods. 2009;1:349-355.
112.
PeriasamySMoFEChenSYChangCCLiuMY. Sesamol attenuates isoproterenol-induced acute myocardial infarction via inhibition of matrix metalloproteinase-2 and -9 expression in rats. Cell Physiol Biochem. 2011;27:273-280.
113.
ChuPYChienSPHsuDZLiuMY. Protective effect of sesamol on the pulmonary inflammatory response and lung injury in endotoxemic rats. Food Chem Toxicol. 2010;48:1821-1826.
114.
ChuPYHsuDZHsuPYLiuMY. Sesamol down-regulates the lipopolysaccharide-induced inflammatory response by inhibiting nuclear factor–kappa B activation. Innate Immun. 2010;16:333-339.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
